Quick Takeaways
- Knight Therapeutics Inc filed SCHEDULE 13G/A for Synergy CHC Corp. Common Stock, par value $0.00001 per share (SNYR).
- Disclosed ownership: 20%.
- Date of event: 11 Jun 2025.
Knight Therapeutics Inc - 11 Jun 2025 SCHEDULE 13G/A Report for Synergy CHC Corp. Common Stock, par value $0.00001 per share (SNYR)
- Filing Manager
- Knight Therapeutics Inc
- Reporting Manager
- KNIGHT THERAPEUTICS INC.
- Symbol
- SNYR
- Shares outstanding
- 9,605,095 shares
- Disclosed Ownership
- 1,911,414 shares
- Ownership
- 20%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Jun 2025, 16:06:03 UTC
- Date of event
- 11 Jun 2025
- Previous filing
- 20 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Knight Therapeutics Inc disclosed 20% ownership in Synergy CHC Corp. Common Stock, par value $0.00001 per share (SNYR) on 11 Jun 2025."
What Changed
- Previous schedule filing date: 20 Mar 2025.
- Current filing was accepted on 13 Jun 2025, 16:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| KNIGHT THERAPEUTICS INC. | 20% | 1,911,414 | 1,911,414 | 0 | /s/ Samira Sakhia | Samira Sakhia / President and Chief Executive Officer |